THE Department of Health has
announced that there is a national
shortage of Saizen solution for
injection (somatropin).
Saizen is subsidised through the
PBS Growth Hormone Program.
The shortage arises from a drug
recall from the supplier of all short
dated Saizen, and the Department
has ceased supplying this PBS item
until sufficient supply is guaranteed.
Patients using Saizen are advised
to ensure that their supply does
not expire before the end of their
treatment period, and if it does, to
contact their pharmacy and doctor
as soon as possible ...
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 08 Aug 12
Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.
To sign up for a free subscription, click on the button at right.
